IGF-1 LR3 1000mcg – Apoxar

IGF-1 LR3 1000mcg – Apoxar

IGF-1 LR3 (Insulin-Like Growth Factor-1 Long R3) – Compound Profile

is a modified version of the naturally occurring Insulin-Like Growth Factor-1 (IGF-1). It has been engineered for enhanced stability, potency, and bioavailability, making it a popular choice among athletes and bodybuilders for its muscle growth and recovery benefits. Apoxar IGF-1 LR3 1000mcg refers to a high-quality, research-grade peptide commonly sold in lyophilized (powder) form for reconstitution.

Key Features of IGF-1 LR3

1. Extended Half-Life:
   • Unlike native IGF-1 (half-life: ~20–30 minutes), IGF-1 LR3 has a significantly extended half-life of ~20–30 hours, enabling once-daily administration.
2. Enhanced Binding Properties:
   • Modified to avoid binding to IGF-binding proteins (IGFBPs), allowing more active IGF-1 to circulate in the bloodstream and exert its effects.
3. Anabolic Potency:
   • Promotes muscle hypertrophy, cell growth, and repair.
   • Potentiates the effects of growth hormone (GH).

Mechanism of Action

IGF-1 LR3 mimics the actions of natural IGF-1 by binding to IGF-1 receptors in muscle, bone, and connective tissues. This activation leads to:

• Protein Synthesis: Promotes muscle growth and recovery.
• Cellular Proliferation: Stimulates cell division and repair in various tissues.
• Nutrient Partitioning: Directs glucose and amino acids into muscle cells for growth.

Benefits of IGF-1 LR3

1. Muscle Growth:
   • Enhances lean muscle tissue growth by increasing protein synthesis and satellite cell activation.
2. Fat Loss:
   • Improves insulin sensitivity and promotes fat oxidation, making it ideal for body recomposition.
3. Improved Recovery:
   • Speeds up recovery from intense workouts by repairing muscle fibers and reducing inflammation.
4. Anti-Aging Effects:
   • Supports skin elasticity, bone density, and overall tissue health.
5. Joint and Tendon Repair:
   • Promotes healing of connective tissues, reducing injury risk.

Dosage and Administration

• Standard Dosage:
  • 20–50 mcg/day, depending on individual goals and tolerance.
  • Some advanced users may go up to 100 mcg/day, but this is less common.
• Injection Timing:
  • Administer subcutaneously (SC) or intramuscularly (IM) in the morning or post-workout for optimal results.
• Cycle Duration:
  • Typically used for 4–6 weeks, followed by an equal time off to avoid desensitization.

Reconstitution and Storage

1. Reconstitution:
   • Mix the 1000mcg (1mg) vial of IGF-1 LR3 with bacteriostatic water or sterile water.
   • For example, if reconstituting with 1 mL of bacteriostatic water, the concentration will be 1000 mcg/mL (1 mcg/μL).
2. Storage:
   • Lyophilized Powder: Store in a cool, dry place (e.g., refrigerator) before reconstitution.
   • After Reconstitution: Store in the refrigerator (2–8°C) and use within 20–30 days.

Potential Side Effects

While IGF-1 LR3 is generally well-tolerated, some users may experience side effects, including:

1. Common:
   • Hypoglycemia (low blood sugar): IGF-1 enhances insulin sensitivity.
   • Localized swelling or irritation at the injection site.
2. Less Common:
   • Headaches.
   • Joint pain (related to rapid growth or repair).
   • Mild water retention.
3. Rare:
   • Excessive growth of tissues (e.g., organs or cartilage) if abused.
   • Insulin resistance with long-term or high-dose use.

Stacking Protocols

IGF-1 LR3 is often used alongside other compounds for enhanced results:

1. With Growth Hormone (GH):
   • Amplifies the anabolic effects of GH by increasing IGF-1 levels systemically.
2. With Anabolic Steroids:
   • Synergizes with steroids like Testosterone or Nandrolone for rapid muscle growth.
3. With Peptides:
   • Combined with GHRP-6 or CJC-1295 to boost growth hormone release and enhance recovery.

Safety and Monitoring

1. Monitoring:
   • Regular blood glucose checks to avoid hypoglycemia.
   • Periodic blood tests to assess IGF-1 levels and ensure safety.
2. Avoiding Desensitization:
   • Do not exceed recommended cycles or doses to prevent receptor downregulation.

Legal and Research Considerations

• Research Status:
  • IGF-1 LR3 is classified as a research peptide and is not FDA-approved for therapeutic use.
• Legal Use:
  • Availability may vary depending on regional regulations; ensure compliance with local laws.